Jean‐Guy Baril

High Rates of Forward Transmission Events after Acute/Early HIV‐1 Infection

Bluma Brenner, Michel Roger, Jean‐Pierre Routy et al. · The Journal of Infectious Diseases · 2007 · 651 citations

Veterinary Medicine, Infectious Diseases, Infectious Disease Epidemiology +7

Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study

Jean‐Michel Molina, Isabelle Charreau, Bruno Spire et al. · The Lancet HIV · 2017 · 472 citations · Full text

Public Health, Infectious Disease Control, Preventive Medicine +16

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

Pedro Cahn, Juan Sierra Madero, José Ramón Arribas et al. · The Lancet · 2018 · 381 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial

Guillemette Antoni, Cécile Tremblay, Constance Delaugerre et al. · The Lancet HIV · 2019 · 79 citations

Public Health, Pharmacology, Pharmacotherapy +17

Atherosclerotic Cardiovascular Disease Risk Profile of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate

Gregory Huhn, David Shamblaw, Jean‐Guy Baril et al. · Open Forum Infectious Diseases · 2019 · 49 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +17